Risk of recurrent stroke in patients with sickle cell disease treated with erythrocyte transfusions

The Journal of Pediatrics

Volumn 126, Issue 6, 1995, Pages 896-899

  Pegelow, Charles H ^a   Adams, Robert J ^a   McKie, Virgil ^a   Abboud, Miguel ^a   Berman, Brian ^a   Miller, Scott T ^a   Olivieri, Nancy ^a   Vichinsky, Elliott ^a   Wang, Winfred ^a   Brambilla, Donald ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

HEMOGLOBIN S;

ADOLESCENT; ADULT; ARTICLE; CHILD; CONTROLLED STUDY; ERYTHROCYTE TRANSFUSION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RECURRENT DISEASE; RISK ASSESSMENT; SICKLE CELL ANEMIA; STROKE;

ADOLESCENT; ADULT; ANEMIA, SICKLE CELL; CEREBRAL INFARCTION; CEREBROVASCULAR DISORDERS; CHILD; CHILD, PRESCHOOL; ERYTHROCYTE TRANSFUSION; FEMALE; HEMOGLOBIN, SICKLE; HUMAN; INFANT; MALE; RECURRENCE;

EID: 0029005136     PISSN: 00223476     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-3476(95)70204-0     Document Type: Article

References (14)

1. The natural history of stroke in sickle cell disease
2. Strokes and their management in sickle cell disease
3. Neurologic manifestations in sickle cell disease
4. Periodic transfusions for sickle cell anemia and CNS infarction
5. Stroke in a cohort of patients with homozygous sickle cell disease
6. A prophylactic transfusion program for children with sickle cell anemia complicated by CNS infarction
7. Effect of transfusion therapy on arteriographic abnormalities and on recurrence of stroke in sickle cell disease
8. Efficacy of transfusion therapy for one to two years in patients with sickle cell disease and cerebrovascular accidents
9. Less intensive long-term transfusion therapy for sickle cell anemia and cerebrovascular accident
10. Delayed intracranial hemorrhage following cerebral infarction in sickle cell anemia
11. High risk of recurrent stroke after discontinuance of five to twelve years of transfusion therapy in patients with sickle cell disease
12. Recurrent cerebral ischemia during hypertransfusion therapy in sickle cell anemia